The 10 risk models that we analyzed have so far not been reported to be related to tumor immunity and NF-κB signaling pathway, which will provide new insights into studies on pancreatic cancer cells and tissue variations as well as functions. The gene discussed is NFKB1; the disease is pancreatic neoplasm.